GOLGA6L Inhibitors
GOLGA6L Inhibitors are a class of compounds that, while not directly binding or acting on GOLGA6L, interfere with the broader cellular processes and environments in which GOLGA6L operates. Given that GOLGA6L is associated with the Golgi apparatus, any perturbation to the Golgi's structure, pH, vesicular transport, protein processing, or associated cellular components can indirectly influence the protein's function.
Brefeldin A, Monensin, and Golgicide A, for instance, directly disrupt the Golgi's function, potentially inhibiting GOLGA6L's ability to execute its roles properly. Other compounds, such as Swainsonine and Tunicamycin, modify the biochemical processes within the Golgi, which could impact any enzymatic activities or modifications GOLGA6L is associated with.
SEE ALSO...
| Product Name | CAS # | Catalog # | QUANTITY | Price | Citations | RATING |
|---|---|---|---|---|---|---|
Brefeldin A | 20350-15-6 | sc-200861C sc-200861 sc-200861A sc-200861B | 1 mg 5 mg 25 mg 100 mg | $31.00 $53.00 $124.00 $374.00 | 25 | |
Disrupts the structure of the Golgi apparatus, where GOLGA6L resides, by inhibiting transport between the endoplasmic reticulum and Golgi, potentially impairing the function of GOLGA6L. | ||||||
Monensin A | 17090-79-8 | sc-362032 sc-362032A | 5 mg 25 mg | $155.00 $525.00 | ||
Alters the pH of the Golgi, which may affect GOLGA6L's interaction with other proteins or its structural integrity within the Golgi. | ||||||
Golgicide A | 1005036-73-6 | sc-215103 sc-215103A | 5 mg 25 mg | $191.00 $683.00 | 11 | |
Targets the GBF1 in the Golgi, disturbing Golgi function, potentially impeding GOLGA6L’s function or localization. | ||||||
Nocodazole | 31430-18-9 | sc-3518B sc-3518 sc-3518C sc-3518A | 5 mg 10 mg 25 mg 50 mg | $59.00 $85.00 $143.00 $247.00 | 38 | |
By destabilizing microtubules, it may disrupt the positioning or structural integrity of the Golgi, and thus the proper function of GOLGA6L. | ||||||
Swainsonine | 72741-87-8 | sc-201362 sc-201362C sc-201362A sc-201362D sc-201362B | 1 mg 2 mg 5 mg 10 mg 25 mg | $138.00 $251.00 $631.00 $815.00 $1832.00 | 6 | |
By inhibiting Golgi alpha-mannosidase, it affects protein processing in the Golgi which can influence GOLGA6L mediated processes. | ||||||
Fumonisin B1 | 116355-83-0 | sc-201395 sc-201395A | 1 mg 5 mg | $200.00 $680.00 | 18 | |
By altering sphingolipid metabolism, the structure of the Golgi can be disrupted, which might affect GOLGA6L’s function or localization. | ||||||
Tunicamycin | 11089-65-9 | sc-3506A sc-3506 | 5 mg 10 mg | $172.00 $305.00 | 66 | |
Inhibits N-linked glycosylation, potentially affecting any glycosylation events GOLGA6L might be involved in, or other proteins it interacts with. | ||||||
Thapsigargin | 67526-95-8 | sc-24017 sc-24017A | 1 mg 5 mg | $136.00 $446.00 | 114 | |
By inducing ER stress, this compound could affect the Golgi's function and indirectly impact GOLGA6L's role in the Golgi. | ||||||
Eeyarestatin I | 412960-54-4 | sc-358130B sc-358130 sc-358130A sc-358130C sc-358130D sc-358130E | 5 mg 10 mg 25 mg 50 mg 100 mg 500 mg | $114.00 $203.00 $354.00 $697.00 $1363.00 $5836.00 | 12 | |
By inducing ER stress and inhibiting ER-associated degradation, this can have cascading effects on Golgi function, and thus GOLGA6L. | ||||||